Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Molecular pathogenesis of acquired aplastic anemia
Prajwal C Boddu1, Tapan M Kadia1
1Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Next-generation sequencing reveals acquired aplastic anemia (AA) involves genetic mutations and immune issues, not just autoimmunity. These genetic findings may impact treatment and prognosis, paving the way for better risk assessment.
Area of Science:
- Hematology
- Genetics
- Immunology
Background:
- Acquired aplastic anemia (AA) was traditionally viewed as an autoimmune disorder.
- Recent advancements highlight a more complex pathophysiology involving genetic factors.
Purpose of the Study:
- To explore the genetic landscape of acquired aplastic anemia using next-generation sequencing (NGS).
- To understand the role of immune dysregulation and somatic mutations in AA pathogenesis.
- To investigate the link between AA and myelodysplastic syndrome/acute myeloid leukemia (MDS/AML).
Main Methods:
- Application of next-generation sequencing (NGS) to analyze the genetic profile of acquired aplastic anemia.
- Investigation of immune dysregulation mechanisms contributing to disease pathogenesis.
- Analysis of recurrent somatic mutations and their association with clinical outcomes.
Main Results:
- NGS revealed acquired aplastic anemia involves cytogenetic abnormalities, somatic mutations, telomere attrition, and immune dysregulation.
- Driver mutations in MDS/AML-associated genes suggest a link between clonal hematopoiesis in AA and subsequent myeloid malignancies.
- Specific genetic alterations correlate with treatment response, disease progression, and survival after immunosuppressive therapy.
Conclusions:
- Acquired aplastic anemia is a multifaceted condition with significant genetic underpinnings beyond autoimmunity.
- Somatic mutations in AA may predict clinical course and treatment efficacy.
- Further validation of genetic abnormalities can improve risk stratification for acquired aplastic anemia patients.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Molecular Models
Molecular Orbital Theory II

